Goldman Sachs’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.3M | Buy |
311,000
+106,000
| +52% | +$8.17M | ﹤0.01% | 2334 |
|
|
2025
Q4 | $16.3M | Sell |
205,000
-41,000
| -17% | -$3.23M | ﹤0.01% | 2577 |
|
|
2025
Q3 | $18.5M | Buy |
+246,000
| New | +$16.9M | ﹤0.01% | 2335 |
|
|
2025
Q2 | – | Sell |
-465,000
| Closed | -$31.5M | – | 6128 |
|
|
2025
Q1 | $31.5M | Sell |
465,000
-110,000
| -19% | -$6.58M | 0.01% | 1609 |
|
|
2024
Q4 | $25.8M | Buy |
575,000
+320,000
| +125% | +$18M | ﹤0.01% | 1868 |
|
|
2024
Q3 | $16M | Sell |
255,000
-51,900
| -17% | -$3.03M | ﹤0.01% | 2260 |
|
|
2024
Q2 | $18.1M | Buy |
306,900
+195,500
| +175% | +$12.2M | ﹤0.01% | 1966 |
|
|
2024
Q1 | $8.89M | Sell |
111,400
-182,500
| -62% | -$13.9M | ﹤0.01% | 2579 |
|
|
2023
Q4 | $23.2M | Sell |
293,900
-1,100
| -0.4% | -$78.3K | ﹤0.01% | 1763 |
|
|
2023
Q3 | $20.6M | Buy |
295,000
+98,900
| +50% | +$7.01M | ﹤0.01% | 1776 |
|
|
2023
Q2 | $13.6M | Sell |
196,100
-233,600
| -54% | -$16.6M | ﹤0.01% | 2175 |
|
|
2023
Q1 | $31.9M | Sell |
429,700
-354,100
| -45% | -$29.7M | 0.01% | 1391 |
|
|
2022
Q4 | $73M | Buy |
783,800
+509,400
| +186% | +$49.2M | 0.02% | 890 |
|
|
2022
Q3 | $26.2M | Sell |
274,400
-334,600
| -55% | -$33.1M | 0.01% | 1620 |
|
|
2022
Q2 | $56.4M | Sell |
609,000
-516,100
| -46% | -$50.4M | 0.01% | 1037 |
|
|
2022
Q1 | $114M | Sell |
1,125,100
-15,900
| -1% | -$1.67M | 0.02% | 689 |
|
|
2021
Q4 | $118M | Sell |
1,141,000
-152,500
| -12% | -$14.1M | 0.02% | 716 |
|
|
2021
Q3 | $110M | Buy |
1,293,500
+115,800
| +10% | +$9.7M | 0.02% | 700 |
|
|
2021
Q2 | $98.3M | Buy |
1,177,700
+637,100
| +118% | +$52.2M | 0.02% | 745 |
|
|
2021
Q1 | $40.7M | Buy |
540,600
+369,300
| +216% | +$26.9M | 0.01% | 1335 |
|
|
2020
Q4 | $11.7M | Buy |
171,300
+88,800
| +108% | +$5.78M | ﹤0.01% | 2323 |
|
|
2020
Q3 | $4.82M | Sell |
82,500
-8,200
| -9% | -$510K | ﹤0.01% | 2934 |
|
|
2020
Q2 | $5.89M | Sell |
90,700
-229,800
| -72% | -$14.5M | ﹤0.01% | 2675 |
|
|
2020
Q1 | $19M | Sell |
320,500
-403,794
| -56% | -$27M | 0.01% | 1548 |
|
|
2019
Q4 | $53.8M | Buy |
724,294
+460,800
| +175% | +$32.4M | 0.01% | 1087 |
|
|
2019
Q3 | $16.6M | Buy |
263,494
+239,500
| +998% | +$14.2M | ﹤0.01% | 1930 |
|
|
2019
Q2 | $1.31M | Sell |
23,994
-268,000
| -92% | -$14.4M | ﹤0.01% | 3813 |
|
|
2019
Q1 | $15.7M | Sell |
291,994
-395,564
| -58% | -$24.4M | ﹤0.01% | 2070 |
|
|
2018
Q4 | $45M | Sell |
687,558
-836,242
| -55% | -$62.4M | 0.01% | 1165 |
|
|
2018
Q3 | $120M | Buy |
1,523,800
+1,171,600
| +333% | +$83.8M | 0.03% | 651 |
|
|
2018
Q2 | $22.7M | Buy |
352,200
+181,100
| +106% | +$11.9M | 0.01% | 1786 |
|
|
2018
Q1 | $10.6M | Sell |
171,100
-327,500
| -66% | -$23.5M | ﹤0.01% | 2277 |
|
|
2017
Q4 | $36.1M | Buy |
498,600
+307,000
| +160% | +$22.3M | 0.01% | 1516 |
|
|
2017
Q3 | $15.6M | Buy |
191,600
+2,900
| +2% | +$229K | ﹤0.01% | 2200 |
|
|
2017
Q2 | $15.2M | Sell |
188,700
-469,800
| -71% | -$37.1M | ﹤0.01% | 2177 |
|
|
2017
Q1 | $51.7M | Buy |
658,500
+12,000
| +2% | +$958K | 0.01% | 1205 |
|
|
2016
Q4 | $51M | Buy |
646,500
+133,300
| +26% | +$10.8M | 0.01% | 1256 |
|
|
2016
Q3 | $45.7M | Buy |
513,200
+66,900
| +15% | +$6.31M | 0.01% | 1274 |
|
|
2016
Q2 | $42.7M | Buy |
446,300
+233,100
| +109% | +$23.2M | 0.01% | 1230 |
|
|
2016
Q1 | $22.1M | Sell |
213,200
-464,800
| -69% | -$45.2M | 0.01% | 1653 |
|
|
2015
Q4 | $66.3M | Sell |
678,000
-365,700
| -35% | -$35.8M | 0.02% | 924 |
|
|
2015
Q3 | $101M | Sell |
1,043,700
-185,400
| -15% | -$19.5M | 0.03% | 616 |
|
|
2015
Q2 | $129M | Buy |
1,229,100
+716,500
| +140% | +$73.2M | 0.04% | 524 |
|
|
2015
Q1 | $52.9M | Sell |
512,600
-650,100
| -56% | -$65.8M | 0.02% | 1052 |
|
|
2014
Q4 | $112M | Buy |
1,162,700
+937,600
| +417% | +$82.6M | 0.04% | 614 |
|
|
2014
Q3 | $17.9M | Sell |
225,100
-155,700
| -41% | -$12.3M | 0.01% | 1871 |
|
|
2014
Q2 | $28.7M | Sell |
380,800
-3,400
| -0.9% | -$257K | 0.01% | 1513 |
|
|
2014
Q1 | $28.8M | Sell |
384,200
-163,900
| -30% | -$11.6M | 0.01% | 1470 |
|
|
2013
Q4 | $39.2M | Buy |
548,100
+61,500
| +13% | +$3.95M | 0.01% | 1233 |
|
|
2013
Q3 | $27.6M | Buy |
486,600
+43,800
| +10% | +$2.61M | 0.01% | 1361 |
|
|
2013
Q2 | $25.3M | Buy |
+442,800
| New | +$25.7M | 0.01% | 1363 |
|
Other funds holding CVS
VCM
VPM
Goldman Sachs's CVS Position: Q1 2026 in Review
Goldman Sachs increased its CVS Health (CVS) stake by 54% in Q1 2026, buying an estimated $340M and bringing the position to 12,639,801 shares worth $908M. The position accounts for 0.1% of the portfolio, ranked #184.
Goldman Sachs first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q4 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Goldman Sachs held 12,639,801 shares of CVS Health worth $908M as of Q1 2026.
- Goldman Sachs bought 4,416,955 CVS Health shares in Q1 2026, an estimated $340M.
- CVS Health made up 0.1% of Goldman Sachs's portfolio in Q1 2026, its #184 holding.
- Goldman Sachs first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's CVS Health position peaked at $1.02B in Q4 2023.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.